There were 2 groups in this study. The chart below shows the treatments the
researchers planned to study.
Group 1 Group 2
18 participants 19 participants
• rabeprazole as a tablet by mouth
• acalabrutinib as a capsule
by mouth with water • acalabrutinib as a capsule by mouth
with flat Coca-Cola
• rabeprazole twice each day for
3 days, and then once on the day
• acalabrutinib and water
the participants took acalabrutinib
1 time
• acalabrutinib and flat Coca-Cola 1 time
What happened during this study?
The study started in July 2020 and ended in August 2020.
Before the participants took study treatment, they visited their study site 1
time. This part of the study lasted for up to 4 weeks. At this visit, the study doctors
made sure the participants could join the study. They also:
X did a physical exam and asked about the participants’ medications and any
medical problems they were having
X did a test for COVID-19
X took blood and urine samples
X checked the participants’ heart health using an electrocardiogram, also called
an ECG
The study doctors also did these tests and measurements throughout the study.
4 | Clinical Study Results